Conclusion
OF DISEASE TRANSMISSION
Although iPrEP appeared to have an inverse effect on readiness and willingness to take PrEP when compared to usual care, further utility of this approach is not futile. In future iterations, it is imperative that revisions to the iPrEP tool carefully considers the level of transparency on side effects and daily pill burden needed to motivate PrEP uptake among cisgender Black women. Approaching the content in a similar way that clinicians approach transparency when sharing information about clinical procedures (i.e. surgeries) to patients should be mobilized. Interventionists should be careful to assess the type of knowledge content that aligns with motivation among cisgender women through future qualitative approaches. Researchers designing interventions for cisgender women aiming to increase PrEP access must also pay close attention to the intervention approach used to deliver PrEP related content. As uptake of PrEP is already low among populations who could benefit from it most, specifically cisgender Black women, researchers and interventionists must be very careful to prevent de-motivating this population from accessing PrEP, as this could stave off progress towards our nation’s Ending the HIV Epidemic plan.Educational material regarding PrEP as a bi-monthly injection should be integrated into revised versions of iPrEP as an intervention tool. Future revisions to the iPrEP intervention will encompass the health benefits of HIV prevention and the ability to lower risk of disease transmission, with an emphasis on HIV through PrEP uptake. Revising and refining approaches that can sexually liberate cisgender Black women, while equipping this population with effective prevention tools, is an avenue with the capacity to rid our health communication of stigma and further marginalization when engaging the healthcare system in prevention services.